Abstract
Background
The parasagittal dura, a tissue that lines the walls of the superior sagittal sinus, acts as an active site for immune-surveillance, promotes the reabsorption of cerebrospinal fluid, and facilitates the removal of metabolic waste products from the brain. Cerebrospinal fluid is important for the distribution of growth factors that signal immature neurons to proliferate and migrate. Autism spectrum disorder is characterized by altered cerebrospinal fluid dynamics.
Methods
In this retrospective study, we investigated potential correlations between parasagittal dura volume, brain structure volumes, and clinical severity scales in young children with autism spectrum disorder. We employed a semi-supervised two step pipeline to extract parasagittal dura volume from 3D-T2 Fluid Attenuated Inversion Recovery sequences, based on U-Net followed by manual refinement of the extracted parasagittal dura masks.
Results
Here we show that the parasagittal dura volume does not change with age but is significantly correlated with cerebrospinal fluid (p-value = 0.002), extra-axial cerebrospinal fluid volume (p-value = 0.0003) and severity of developmental delay (p-value = 0.024).
Conclusions
These findings suggest that autism spectrum disorder children with severe developmental delay may have a maldeveloped parasagittal dura that potentially perturbs cerebrospinal fluid dynamics.
Plain language summary
Cerebrospinal fluid (CSF) is produced in the brain. It is a medium of transport for neural growth factors and waste products. CSF is drained out of the brain through multiple pathways, one of them being the recently identified parasagittal dura (PSD) which also plays a role in the immune system within the brain. We estimated the PSD volume in children with autism spectrum disorder (ASD) and found the volume was associated with the amount of CSF in the brain. We also found that the PSD volume is smaller in children who have severe forms of developmental delay. Our findings suggest problems in the development of the PSD could have in impact on brain development and waste removal in children with ASD. More research in this area could enable a better understanding of the underlying causes of ASD.
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Introduction
The parasagittal dura (PSD) is a parasinus tissue located along the exterior walls of the superior sagittal sinus1. The PSD hosts meningeal lymphatic channels, stromal elements, immune cells, and arachnoid granulations2,3,4,5. Recent experimental studies demonstrate that this dura-arachnoid tissue serves multiple roles: acts as a conduit for the flow of cerebrospinal fluid (CSF) towards meningeal lymphatics (MLs), facilitates the elimination of metabolic waste from the brain and plays a pivotal role in brain immune-surveillance6,7,8,9,10. PSD contains diverse immune cell subsets actively monitoring for cerebral antigens that find their way into peripheral lymph nodes11,12.
There are few studies that have employed magnetic resonance imaging (MRI) to quantify the volume of PSD in adults13,14,15. PSD volumes increase during lifespan which is likely a compensatory response to age-related impairment of the lymphatic drainage and MLs13,14,16.
In patients with Alzheimer’s disease, PSD volume was directly correlated with a greater load of amyloid beta deposition in the brain parenchyma, suggesting that a hypertrophic PSD reflects altered dynamics in neurofluids and poor waste clearance17.
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by heterogeneous manifestations of symptoms. These include stereotypical behaviors and social and communication skill deficits18. Epidemiologic studies suggest that the prevalence of ASD is increasing worldwide estimated at 27.6 per 1000 children19. The increase in prevalence is likely a combination of enhanced diagnostic criteria but also the presence of more recently discovered epigenetic and multiple environmental factors. The etiology of ASD remains largely elusive with both genetic and environmental factors being variably involved in the expression of ASD phenotype18,20,21.
Some evidence suggests that CSF dynamics are disrupted in ASD, potentially due to an imbalance between CSF production and absorption22,23. Furthermore, several studies have suggested that immunological dysregulation in children with ASD initiates a subtle neuroinflammatory process that hinders typical development of the central nervous system24,25.
MRI is a non-invasive tool to study the anatomy, biochemistry, and function of the brain. While the diagnosis of ASD is based mostly on clinical scales, an MRI is usually requested to rule out structural or organic etiologies of cognitive dysfunction26. To date, no studies have evaluated PSD in the developing brain. Our objective was to delineate PSD within our in-patient ASD cohort and explore potential correlations between PSD volume, brain tissue volumes, and clinical severity scales in ASD by utilizing a semi-automatic segmentation pipeline including a convolutional neural network and manual refinement. Our results suggest that PSD volume does not change with age but is significantly correlated with CSF, extra-axial cerebrospinal fluid volume, and severity of developmental delay in patients with ASD.
Methods
Ethical approval
This retrospective study was approved by the IRCCS Eugenio Medea Institutional Review Board (Protocol No. 1022) and written informed consent was obtained from all legal representatives (parents or legal guardians) of the children.
Study participants
Children clinically diagnosed with ASD were selected for this study. The diagnosis was conducted by a multidisciplinary team at the Child Psychopathology Unit of the Scientific Institute IRCSS E. Medea (Bosisio Parini, Italy), according to DSM-5 criteria (American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders. Fifth edition. Washington, DC: American Psychiatric Association) and regardless of the presence of global developmental delay or intellectual disability. The diagnostic instruments employed included the Autism Diagnostic Interview–Revised (ADI-R)27 administered to parents and the Autism Diagnostic Observation Schedule-second edition (ADOS-2)28 conducted with the child. The Calibrated Severity Score (CSS) was employed as a metric for assessing the severity of autistic symptoms29,30. The scale ranges from 1 to 10, classifying severity into three categories: 1–3 for non-spectrum, 4–5 for autism spectrum disorder, and 6–10 for autism. IQ was assessed using either the Wechsler Intelligence Scale for Children (WISC-IV)31 or the Wechsler Preschool and Primary Scale of Intelligence-III (WPPSI-III)31 selecting the test based on the child’s age and cognitive-linguistic abilities. For children unable to complete these tests due to lack of cooperation, age, or absence/difficulty with language, we conducted a psychomotor development assessment using the Griffiths Mental Development Scales (cGMDS-ER)32. IQ scores were further grouped into four classes: normal (>70), mild (50–70), moderate (35–49), and severe (20–34). This classification was preferred over the use of a continuous variable because we believe that global functioning is a variable that correlates better with neuroradiological data than small numerical variations within the functioning class. As part of the clinical diagnostic process, all children underwent brain MRI examinations, as well as etiologic instrumental investigations, such as electroencephalograms and genetic tests, between January 2022 and March 2023. The initial clinical sample consisted of a total of 67 patients with a diagnosis of ASD. The following criteria led to the exclusion of patients from the study: (1) age less than 2 or greater than 8 years and; (2) reduced MRI quality. As a result, this retrospective study included a total of 56 children.
MRI acquisition protocol
All our participants were sedated with continuous intravenous infusion of propofol. MRI data were acquired on a 3T scanner (Achieva dStream; Philips Medical Systems) with a 32-channel head coil at the Diagnostic Imaging and Neuroradiology Unit of the Institute. The MRI protocol included two anatomical sequences: (a) 3D-T1 weighted (3D-T1w): sagittal scanning plane; repetition time (TR) = 8,3 ms; echo time (TE) = 3,9 ms; echo train length (ETL) = 256; flip angle = 8°; 1 average; 1 × 1 × 1 mm3 voxel size. Acquisition time: 5 min and 38 s; (b) 3D-T2 Fluid Attenuated Inversion Recovery (3D-FLAIR): sagittal scanning plane; TR = 4800 ms; TE = 298 ms; inversion time = 1650 ms; ETL = 167; flip angle = 90°; 2 averages; 1 × 1 × 1 mm3 voxel size. Acquisition time: 6 min.
MRI volumetric assessment
3D-T1w images were processed using an ad-hoc pipeline developed in-house which briefly consists in the following steps: (1) brain extraction from the acquired images combining multiple tools [BET, ROBEX, ANTS]33,34,35, (2) bias field intensity artifacts correction using the N4BC algorithm36, (3) rigid registration to MNI space37, and (4) segmentation of the main brain structures with Atropos using the PTBP (Pediatric Template of Brain Perfusion) priors34. From the processed 3D-T1w images the following volumes were derived for each child: ICV, CSF, WM, and cGM. The ea-CSF was derived from the CSF mask by manually removing the ventricles and the component below the anterior commissure – posterior commissure line (AC-PC line) (Fig. 1)23.
PSD segmentation and volumetric assessment
PSD segmentation was obtained from 3D-FLAIR images as they provide a larger contrast between the PSD and the CSF than the 3D-T1w images. Acquired images were processed using the N4 algorithm to remove any bias field intensity artifact.
In this context, convolutional neural networks (CNNs), particularly the U-Net architecture and its variants, have become the state-of-the-art approach to perform an automatic and user-independent segmentation38,39. Thus, we developed an in-house 2D U-Net backbone-based architecture with the intent to facilitate the segmentation process40. Notably, the network was trained on an independent dataset including 10 healthy adults (32.6 ± 12.5 years) whose images were manually segmented by an expert neuroradiologist. Each participant dataset comprised at least 150 images for a total training set of 2250 coronal images. Validation was performed on 418 coronal images from 2 healthy adults and the test set comprised 1941 coronal images derived from 10 ASD children. This U-Net was then applied to our cohort of 56 children with ASD. All the resulting segmentations were manually refined by the neuroradiologist to correct for erroneous segmentations. The performance metrics between the U-Net-based automatic segmentation results and the manually corrected segmentations are presented in Supplementary Figs. S1 and S2. The U-Net architecture was employed given the constrained training dataset, as implemented in previous PSD segmentation studies39.
The anterior and the posterior segments of PSD in the very young developing brain are either absent or very difficult to disentangle from the surrounding brain structures. Furthermore, the PSD aspect in the anterior and posterior segments is very different from the central one due to the relative inclination of the coronal plane with the PSD skeleton direction. As a consequence, we decided to restrict the PSD segmentation to its central components to enhance reproducibility. More precisely, we delineated a region of interest for the PSD segmentation by tracing an arc on the cranial circumference, subtended by a 60° angle passing through the anterior commissure-posterior commissure (AC-PC) landmarks (Fig. 1). Finally, the volume of the central component of the PSD was derived from the segmentation and used as a proxy of the whole PSD volume.
Statistics
This study involved the presence of both continuous (e.g., brain structure volumes, age) and categorical variables (e.g., IQ classes, ADOS). The normal distribution of variables was verified with the Shapiro–Wilk test and compared using the student’s t-test for independent samples. Correlations were determined by Kendall correlation tests. ANOVA test was used for assessing differences between groups in categorical variables. Data were analyzed using statistical analysis with R setting the significant threshold for the p-value to 0.05 or p-value of 0.01 in the case of Bonferroni correction. In the analysis comparing PSD volume with five distinct cerebral volumes (ICV, WM, cGM, CSF, and ea-CSF), the Bonferroni correction was utilized to tackle the issue of multiple comparisons in statistical testing. This correction involved setting the p-value threshold at 0.01 (calculated as 0.05 divided by the number of comparisons), ensuring a more stringent criterion for determining statistical significance in each individual comparison.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Results
Study participants
The study included 56 patients with confirmed ASD diagnoses that met the inclusion criteria defined in the Materials and Methods section. The characteristics of the study participants are provided in Table 1.
Brain volumetrics and age
The average volumes of intracranial volume (ICV), cortical gray matter (cGM), white matter (WM), CSF, extra-axial CSF (ea-CSF), and PSD are reported in Table 2. A significant age-related increase in ICV (R = 0.28, p-value = 0.00027), WM (R = 0.34, p-value = 0.0002), and cGM (R = 0.18, p-value = 0.049) was observed. In contrast, no significant correlations were found with, CSF, ea-CSF, and PSD with age, as depicted in Fig. 2.
PSD and brain volumes
An example of PSD segmentation is represented in Fig. 3. The average PSD volume was 5 ± 2 cm³. Significant correlations were identified between PSD volume and ea-CSF volume (R = 0.33; p-value = 0.0003), CSF volume (R = 0.29; p-value = 0.002) (Fig. 4). No correlations were identified between PSD volume and ICV, WM, or cGM (Table 3).
PSD volume and clinical scores
PSD volume displayed an overall significant inverse relationship with IQ class (p-value = 0.0242, F-value = 3.071; one-way ANOVA) (Fig. 5), but not with ADOS-2 CSS scale (p-value = 0.126, F-value = 2.157; one-way ANOVA). Subsequent post-hoc analyses showed only a significant difference in the PSD volume between patients with normal and with severe IQ deficit scores (p-value = 0.022; one-tailed t-test). No other brain structure volume was correlated with clinical severity.
PSD and ea-CSF volume correlation in developmental delay
In children with severe developmental delay, the PSD volume is smaller compared to those with normal IQ, despite having the same volume of ea-CSF. In other words, the correlation between PSD volume and ea-CSF fails to reach statistical significance in children with severe developmental delay (R = 0.103; p-value = 0.6), whereas, in children with normal IQ, this correlation appears to be statistically significant (R = 0.515; p-value = 0.02) (Fig. 6).
Discussion
The role of PSD as a CSF-draining pathway is unexplored in both healthy developing children and ASD. We found a robust positive correlation between PSD volume, CSF, and ea-CSF volume and an inverse relationship between PSD volume and the severity of developmental delay, or IQ, in our cohort of ASD children. Severe developmental delay may be a consequence of an underdeveloped PSD which is inefficient in draining CSF, contributing thereby to the accumulation of toxic substances and promoting subtle neuroinflammatory processes often associated with ASD25,41,42. These findings hold importance in light of the growing understanding of the role that PSD plays in promoting the drainage of CSF from the brain, in the removal of waste materials, and in facilitating immune-survellaince1,25,43.
The ea-CSF has been described as the CSF space that envelops the cerebral dorsal subarachnoid space which contains CSF that is in direct proximity with the cerebral meninges and PSD23. It excludes the ventricular space and the lower or ventral portion of the subarachnoid space. Increased ea-CSF volume is a well-documented potential MRI biomarker in children with ASD and those at high risk of developing ASD22,23,44. Our findings add to the substantial body of literature that indicates altered CSF dynamics in this population22,42.
In the traditional model, arachnoid granulations (AGs) are recognized as the primary sites of CSF absorption45. A recent study described five different types of AGs in the adult brain possessing different capacities for CSF transfer into MLs46. AGs typically reach maturity by the age of 18 months, but their numbers change over the lifespan47,48. In some individuals, AGs are completely absent without changes in CSF homeostasis, suggesting that there are alternative routes to CSF absorption, the PSD being one of them47,49.
Age-related developmental trajectories for WM and cGM are well-documented in typically developing children with cGM showing an inverted U-shape growth trajectory compared to the WM that continues to increase till early adulthood50,51. In our cohort, WM, cGM, and ICV volumes increased with age. This closely mirrors the developmental trajectories reported in a large longitudinal study on children with ASD and normally developing children52. The structural organization of the brain tissue and the maturation process of CSF production and absorption pathways in the developing brain are thought to affect CSF volume trajectories with age53. Recent works suggest that beyond the age of 4 years, no change in ea-CSF is observed in children with ASD54,55. Our work also confirms that the volume of ea-CSF does not change with age.
The development of meninges in the postnatal period reveals that MLs, including the meninges and the calvarium, continue to develop postnatally56,57. Although a few studies have explored PSD volume in healthy adults and individuals with neurodegenerative conditions, the PSD volume in both typically developing children and those with ASD has yet to be explored in the literature. Melin et al. 15 reported a PSD volume of 4.19 ± 2.07 cm3 in a heterogeneous group comprising healthy adults and individuals with CSF disorders, whereas Song et al. reported an average PSD volume of 11.85 ± 2.16 cm3 among adults diagnosed with Alzheimer’s disease15,17. Therefore, although direct evidence is lacking, the growth trajectory of PSD in the developing brain is expected to follow the growth of the meninges, the dural venous system, and the calvarium in early childhood58. The volume of PSD did not correlate with the volumes of WM, cGM, or ICV but it strongly correlated with the volumes of CSF and ea-CSF. Although we report findings on children, they align with existing literature that has utilized similar deep learning-based algorithms to derive PSD volumes in adult humans over the age of 20 years13,14,16. These results further emphasize the crucial role of PSD in the exchange of CSF from the dorsal subarachnoid space.
In our study, PSD volume did not correlate with cGM or WM volumes13,14. Again, this finding is in line with literature on adults in which PSD volume was not correlated to age-related brain atrophy but rather only with CSF volume, underscoring the important link between CSF and PSD16. In a separate study involving patients with Alzheimer’s disease, PSD volumes were significantly correlated with an increasing burden of amyloid beta deposition with no significant correlation observed with overall brain atrophy17. Furthermore, while studies in human adults reveal a significant positive association between PSD volume and age, in our study no age-related effect on PSD volume was observed notwithstanding changes in aforementioned brain volumes over age. Further studies are required to fully comprehend the normal development of PSD in the developing brain. In addition, there is little understanding of the relationship between PSD volume and its CSF-draining capacity in very young children, and needs further investigation.
Another noteworthy finding in our study is the inverse relationship between PSD volumes and IQ scores among children with ASD. This observation implies that children with severe developmental delay also have a smaller PSD compared to children with normal IQ. The recent discoveries of the role of PSD and the MLs may shed some light on CSF dynamics that are altered in ASD1,2,7,43. The hypotrophic PSD in ASD children with severe developmental delay may harbor hypoplastic MLs, initiating a chain of events that hampers CSF drainage, leads to the accumulation of cerebral toxins, and triggers neuroinflammatory processes affecting brain development59. Although an inverse relationship was found between PSD volume and the degree of developmental delay, it is noteworthy that CSF volume remains constant across various IQ levels (Fig. 7). No correlations were found with the ADOS-2 CSS scale.
It is well-known that PSD is not the only pathway for CSF efflux. Since the ea-CSF volume remained constant in children with normal and severe developmental delay, it is likely that CSF drains more effectively through other CSF-draining pathways. Previous investigations have underscored the primary involvement of PSD in neuroimmune functions, positing its role in CSF drainage as secondary. It is important to note that our study cohort predominantly consists of children with moderate to severe ASD, which limits our ability to establish meaningful correlations with milder forms of the condition. On the contrary, our discoveries unveil a Pandora’s box, suggesting that the investigation of MLs in ASD could potentially unlock neuroinflammatory processes and alter CSF homeostasis in ASD.
Meningeal cells play crucial roles in guiding the development of ventricular radial glial cells, ensuring proper neuronal development, and are heavily involved in neuro-immune functions60. While the specific origin of PSD is unknown, it is likely that this tissue contains meningeal cells and meningeal stroma, as it lies within the two layers of the dura mater. Meningeal neural progenitors migrate through multiple pathways within the brain parenchyma, contributing to cortical development, guiding neuronal connectivity, and forming membranes that delineate perivascular spaces around penetrating arterioles61,62. Findings from 16p11.2 mouse models of ASD clearly identify that endothelium is dysfunctional and affects the stability of blood vessels. This contributes to behavioral changes specific to ASD. Proper angiogenesis is also fundamental for optimal neurogenesis63. Anomalies in meningeal tissue development during the early stages of life, potentially influenced by genetic or epigenetic factors, may also contribute to established neuronal dysconnectivity in ASD. Our study suggests that PSD is underdeveloped in children with ASD who suffer more severe developmental delays. While additional investigations are necessary, it is proposed that a poorly developed PSD could potentially impact developmental processes, and promote neuroinflammation leading to dysregulation of neuronogenesis and angiogenesis.
In addition to PSD volumes, dilated perivascular spaces (DPVS) are considered indirect markers of obstructed drainage of fluids64,65,66,67. Only one study has examined DPVS in young children with ASD which reports a non-significant increase in the prevalence of DPVS in kids with severe form of ASD68. Our observations add to the literature whereby some form of obstruction to the movement of neurofluids may be present in ASD10.
Our choice for employing 3D-FLAIR to segment PSD was based on previous initial work employing 3D-FLAIR for imaging MLs and quantifying the volume of PSD1,3,15,69. 3D-FLAIR is commonly used in the standard MRI protocol and is readily accessible. Neither contrast-enhanced T2-weighted black blood sequence nor sub-millimetric 3D-T2-weighted sequences that have been used in other studies to segment PSD were available in this retrospective study13,14.
Our research paves the way for exploring newer avenues in the assessment of children with ASD, with the aim of identifying MRI markers suggestive of altered fluid dynamics and identifying treatment strategies. To achieve this, there are several critical steps to consider. Firstly, it is essential to establish quantitative measurements of PSD volumes in the developing brain. Secondly, the correlation between PSD volumes and serum-based markers of proinflammation should be investigated to gain deeper insights into the neuroinflammatory mechanisms involved. Thirdly, research into potential genetic alterations in children with ASD that could contribute to the underdevelopment of PSD and MLs warrants examination.
The primary constraint in our study is the lack of a reference group of typically developing children within our specified age range. There are no publicly available datasets in healthy young children that have 3D-FLAIR images that were employed for our deep learning algorithm for PSD segmentation, following established methods outlined in the work of Melin et al.15. Large datasets on children younger than 5 years is even more scarce. Our institution’s primary focus is on the diagnosis and treatment of very young children with moderate to severe neurodevelopmental disorders, which positions us favorably in acquiring MRI in young children with ASD. However, this specialized focus limits our ability to readily assemble a comparable group of healthy children. Nonetheless, this study provides greater insight and hope in our understanding of this devastating condition on the rise worldwide. Another limitation pertains to our sample size. We employed strict recruiting criteria to eliminate confounding factors. This still resulted in a sample size sufficient to detect significant associations between PSD volume, CSF, ea-CSF volume, and IQ class in ASD. A third limitation concerns the PSD segmentation pipeline. The scientific community lacks consensus on the methods, procedures, and even the types of images to be used for PSD segmentation. To address this, we utilized a cutting-edge segmentation method to generate the PSD mask from our images and incorporated a manual correction step to rectify any remaining errors. Furthermore, we confined the PSD segmentation to its central component to enhance the reproducibility of the process. Nevertheless, it is important to acknowledge that each of these choices may have an impact on the ultimate results. Lastly, we are aware that sedation can affect the dynamics of neurofluids. Animal research studies indicate that glymphatic clearance in the interstitial space increases during natural sleep and sedation with ketamine70. In another study, rats sedated with propofol exhibited an expansion of the extracellular space with improved interstitial fluid (ISF) drainage compared to other anesthetics like isoflurane71. While preclinical research suggests that sedation positively influences ISF drainage, human studies are lacking. It remains uncertain whether a 30-min sedation period in our study would result in significant changes in the PSD volume. This would be subject to further investigation. Even if we hypothesize an increased rate of CSF efflux into PSD during sedation, we would not expect our results to change because all our patients were under the same experimental condition during MR acquisition. Eide and Ringstad demonstrated that the rate of molecular clearance via PSD is not affected by sleep but there are no studies that determine changes in PSD volume with sleep or sedation in humans or in animals72. Successful implementation of MRI during deep sleep in young children would be ideal, however, this necessitates the creation of a specific ambiance and modification of the MRI protocol to allow for a shorter duration of the scan73. Such scanning poses practical challenges in our research studies, which remain currently difficult to navigate.
Conclusions
This study suggests that an underdeveloped PSD may contribute to the severity of developmental delay in children with a diagnosis of ASD. Furthermore, PSD volume correlated only with total CSF and ea-CSF volume which validates its role in CSF drainage and strongly supports the emerging and ongoing revelation of CSF exchange between the subarachnoid space and the PSD.
Data availability
All source data relative to images are available from the corresponding author on reasonable request. All source data to produce graphs in Figures 2, and 4–6 are available at https://doi.org/10.6084/m9.figshare.24582369.v474.
Code availability
Codes and software versions used are available at https://doi.org/10.6084/m9.figshare.24582369.v474.
References
Ringstad, G. & Eide, P. K. Cerebrospinal fluid tracer efflux to parasagittal dura in humans. Nat. Commun. 11, 1–9 (2020).
Aspelund, A. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212, 991–999 (2015).
Absinta, M. et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. Elife 6, 780 (2017).
Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337–341 (2015).
Rustenhoven, J. et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000–1016.e27 (2021).
Raper, D., Louveau, A. & Kipnis, J. How do meningeal lymphatic vessels drain the CNS? Trends Neurosci. 39, 581–586 (2016).
Tavares, G. A. & Louveau, A. Meningeal lymphatics: an immune gateway for the central nervous system. Cells 10, 1–11 (2021).
Ahn, J. H. et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572, 1–29 (2019).
Louveau, A. et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat. Neurosci. 21, 1380–1391 (2018).
Agarwal, N. et al. Current understanding of the anatomy, physiology, and magnetic resonance imaging of neurofluids: update from the 2022 “ISMRM Imaging Neurofluids Study group” workshop in Rome. J. Magn. Reson. Imaging 59, 431–449 (2024).
Alves de Lima, K., Rustenhoven, J. & Kipnis, J. Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Annu. Rev. Immunol. 38, 597–620 (2020).
Rustenhoven, J. & Kipnis, J. Brain borders at the central stage of neuroimmunology. Nature 612, 417–429 (2022).
Park, M., Kim, J. W., Ahn, S. J., Cha, Y. J. & Suh, S. H. Aging is positively associated with peri‐sinus lymphatic space volume: assessment using 3T black‐blood MRI. J. Clin. Med. 9, 1–10 (2020).
Hett, K. et al. Parasagittal dural space and cerebrospinal fluid (CSF) flow across the lifespan in healthy adults. Fluids Barriers CNS 19, 1–14 (2022).
Melin, E., Ringstad, G., Valnes, L. M. & Eide, P. K. Human parasagittal dura is a potential neuroimmune interface. Commun. Biol. 6, 260 (2023).
Melin, E., Eide, P. K. & Ringstad, G. In vivo assessment of cerebrospinal fluid efflux to nasal mucosa in humans. Sci. Rep. 10, 14974 (2020).
Song, A. K. et al. Parasagittal dural space hypertrophy and amyloid-β deposition in Alzheimer’s disease. Brain Commun. 5, 1–12 (2023).
Muhle, R. A., Reed, H. E., Stratigos, K. A. & Veenstra-VanderWeele, J. The emerging clinical neuroscience of autism spectrum disorder. JAMA Psychiatry 75, 514 (2018).
Maenner, M. J. et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveill Summ 72, 1–14 (2023).
Yin, J. & Schaaf, C. P. Autism genetics – an overview. Prenat. Diagn. 37, 14–30 (2017).
Rylaarsdam, L. & Guemez-Gamboa, A. Genetic causes and modifiers of autism spectrum disorder. Front. Cell. Neurosci. 13, 385 (2019).
Shen, M. D. Cerebrospinal fluid and the early brain development of autism. J. Neurodev. Disord. 10, 1–10 (2018).
Shen, M. D. et al. Early brain enlargement and elevated extra-axial fluid in infants who develop autism spectrum disorder. Brain 136, 2825–2835 (2013).
Toscano, C. V. A. et al. Neuroscience and biobehavioral reviews neuroinflammation in autism spectrum disorders: exercise as a “pharmacological” tool. Neurosci. Biobehav. Rev. 129, 63–74 (2021).
Hughes, H. K., Moreno, R. J. & Ashwood, P. Brain behavior and immunity innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD). Brain Behav. Immun. 108, 245–254 (2023).
Ambrosino, S. et al. In-depth characterization of neuroradiological findings in a large sample of individuals with autism spectrum disorder and controls. NeuroImage Clin. 35, 1–11 (2022).
Rutter, M., Le Couteur, A., and Lord, C. Autism Diagnostic Interview-Revised (Western Psychological Services, 2003).
Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K. Autism Diagnostic Observation Schedule 2nd edn (ADOS-2) (Western Psychological Services, 2012).
Gotham, K., Pickles, A. & Lord, C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J. Autism Dev. Disord. 39, 693–705 (2009).
Esler, A. N. et al. The autism diagnostic observation schedule, toddler module: standardized severity scores. J. Autism Dev. Disord. 45, 2704–2720 (2015).
Wechsler, D. Wechsler Intelligence Scale for Children – Fourth UK Edition (WISC-IV UK) (British Psychological Society). https://doi.org/10.53841/bpstest.2004.wisc4. (2004).
Luiz, D. M., Foxcroft, C. D. & Povey, J.-L. The griffiths scales of mental development: a factorial validity study. South Afr. J. Psychol. 36, 192–214 (2006).
Iglesias, J. E., Liu, C. Y., Thompson, P. M. & Tu, Z. Robust brain extraction across datasets and comparison with publicly available methods. IEEE Trans. Med. Imaging 30, 1617–1634 (2011).
Avants, B. B., Tustison, N. J., Wu, J., Cook, P. A. & Gee, J. C. An open source multivariate framework for n-tissue segmentation with evaluation on public data. Neuroinformatics 9, 381–400 (2011).
Pechaud, M., Jenkinson, M. & Smith, S. BET2: MR-based estimation of brain, skull and scalp surfaces. In Eleventh Annual Meeting of the Organization for Human Brain Mapping (John Wiley and Sons, 2005).
Tustison, N. J. et al. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging 29, 1310–1320 (2010).
Avants, B., Epstein, C., Grossman, M. & Gee, J. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med. Image Anal. 12, 26–41 (2008).
Siddique, N., Paheding, S., Elkin, C. P. & Devabhaktuni, V. U-Net and its variants for medical image segmentation: a review of theory and applications. IEEE Access 9, 82031–82057 (2021).
Ronneberger, O., Fischer, P. & Brox, T. U-Net: convolutional networks for biomedical image segmentation. In 234–241 https://doi.org/10.1007/978-3-319-24574-4_28 (2015).
Ciceri, T. et al. Review on deep learning fetal brain segmentation from magnetic resonance images. Artif. Intell. Med. 143, 102608 (2023).
Bjørklund, G. et al. Immune dysfunction and neuroinflammation in autism spectrum disorder. Acta Neurobiol. Exp. 76, 257–268 (2016).
Runge, K. et al. Cerebrospinal fluid findings of 36 adult patients with autism spectrum disorder. Brain Sci. 10, 1–18 (2020).
Ringstad, G. & Eide, P. K. Molecular trans-dural efflux to skull bone marrow in humans with CSF disorders. Brain 145, 1464–1472 (2022).
Shen, M. D. et al. Increased extra-axial cerebrospinal fluid in high-risk infants who later develop autism. Biol. Psychiatry 82, 186–193 (2017).
Lewis, H. W. The pathways of escape from the subarachnoid spaces with particular reference to the arachnoid villi. J. Med. Res. XXXI, 50–96 (1914).
Shah, T. et al. Arachnoid granulations are lymphatic conduits that communicate with bone marrow and dura-arachnoid stroma. J. Exp. Med. 220, e20220618 (2023).
Radoš, M., Živko, M., Periša, A., Orešković, D. & Klarica, M. No arachnoid granulations—no problems: number, size, and distribution of arachnoid granulations from birth to 80 years of age. Front. Aging Neurosci. 13, 698865 (2021).
Gómez, D. G. et al. Development of arachnoid villi and granulations in man. Cells Tissues Organs 111, 247–258 (1981).
Klarica, M., Radoš, M. & Orešković, D. The movement of cerebrospinal fluid and its relationship with substances behavior in cerebrospinal and interstitial fluid. Neuroscience 414, 28–48 (2019).
Coupé, P., Catheline, G., Lanuza, E. & Manjón, J. V. Towards a unified analysis of brain maturation and aging across the entire lifespan: a MRI analysis. Hum. Brain Mapp. 38, 5501–5518 (2017).
Tanaka, C., Matsui, M., Uematsu, A., Noguchi, K. & Miyawaki, T. Developmental trajectories of the fronto-temporal lobes from infancy to early adulthood in healthy individuals. Dev. Neurosci. 34, 477–487 (2013).
Lee, J. K. et al. Archival report longitudinal evaluation of cerebral growth across childhood in boys and girls with autism spectrum disorder. Biol. Psychiatry 90, 286–294 (2021).
Fame, R. M. & Lehtinen, M. K. Review emergence and developmental roles of the cerebrospinal fluid system. Dev. Cell 52, 261–275 (2020).
Peterson, M., Whetten, C., Clark, A. M. & Nielsen, J. A. No difference in extra-axial cerebrospinal fluid volumes across neurodevelopmental and psychiatric conditions in later childhood and adolescence. J. Neurodev. Disord. 15, 1–13 (2023).
Gogtay, N. et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc. Natl Acad. Sci. USA 101, 8174–8179 (2004).
Antila, S. et al. Development and plasticity of meningeal lymphatic vessels. J. Exp. Med. 214, 3645–3667 (2017).
Weller, R. O., Sharp, M. M., Christodoulides, M., Carare, R. O. & Møllgård, K. The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS. Acta Neuropathol 135, 363–385 (2018).
Frassanito, P. et al. The growth of the neurocranium: literature review and implications in cranial repair. Childs Nerv. Syst. 35, 1459–1465 (2019).
Yanev, P. et al. Impaired meningeal lymphatic vessel development worsens stroke outcome. J. Cereb. Blood Flow Metab. 79, 271678X18822921 (2019).
Decimo, I. et al. Meninges: a widespread niche of neural progenitors for the brain. Neuroscientist 27, 506–528 (2021).
Bifari, F. et al. Meninges harbor cells expressing neural precursor markers during development and adulthood. Front. Cell. Neurosci. 9, 383 (2015).
Azmitia, E. C., Saccomano, Z. T., Alzoobaee, M. F., Boldrini, M. & Whitaker-Azmitia, P. M. Persistent angiogenesis in the autism brain: an immunocytochemical study of postmortem cortex, brainstem and cerebellum. J. Autism Dev. Disord. 46, 1307–1318 (2016).
Vasudevan, A., Long, J. E., Crandall, J. E., Rubenstein, J. L. R. & Bhide, P. G. Compartment-specific transcription factors orchestrate angiogenesis gradients in the embryonic brain. Nat. Neurosci. 11, 429–439 (2008).
MacGregor Sharp, M. et al. Demonstrating a reduced capacity for removal of fluid from cerebral white matter and hypoxia in areas of white matter hyperintensity associated with age and dementia. Acta Neuropathol. Commun. 8, 131 (2020).
Wardlaw, J. M. et al. Reply to: rethink the classical view of cerebrospinal fluid production. Nat. Rev. Neurol. 17, 590–591 (2021).
Brown, R. et al. Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc. Res. 114, 1462–1473 (2018).
Wardlaw, J. M. et al. Perivascular spaces in the brain: anatomy, physiology and pathology. Nat. Rev. Neurol. https://doi.org/10.1038/s41582-020-0312-z (2020).
Sotgiu, M. A. et al. Brain perivascular spaces and autism: clinical and pathogenic implications from an innovative volumetric MRI study. Front. Neurosci. 17, 1–10 (2023).
Albayram, M. S. et al. Non-invasive MR imaging of human brain lymphatic networks with connections to cervical lymph nodes. Nat. Commun. 13, 1–14 (2022).
Benveniste, H., Heerdt, P. M., Fontes, M., Rothman, D. L. & Volkow, N. D. Glymphatic system function in relation to anesthesia and sleep states. Anesth. Analg. 128, 747–758 (2019).
Zhao, G., Han, H., Wang, W. & Jia, K. Propofol rather than isoflurane accelerates the interstitial fluid drainage in the deep rat brain. Int. J. Med. Sci. 18, 652–659 (2021).
Eide, P. K. & Ringstad, G. Cerebrospinal fluid egress to human parasagittal dura and the impact of sleep deprivation. Brain Res. 1772, 147669 (2021).
Dean, D. C. 3rd et al. Pediatric neuroimaging using magnetic resonance imaging during non-sedated sleep. Pediatr. Radiol. 44, 64–72 (2014).
Nivedita Agarwal, G. F. et al. Parasagittal dural space is linked to cerebrospinal fluid in young children with autism spectrum disorder. Figshare https://doi.org/10.6084/m9.figshare.24582369.v4 (2024).
Acknowledgements
This study was supported by the Italian Ministry of Health (Ricerca Corrente 2024) and 5 × 1000 funds for biomedical research.
Author information
Authors and Affiliations
Contributions
Project administration: N.A., L.L.; software - implementation of the computer code and supporting algorithms: L.L., G.R., T.C.; patient recruitment: F.L., E.M.; formal analysis and visualization: G.F., T.C., L.L., D.P., G.R.; Administration and writing of the original draft N.A.; writing – editing: G.F., L.L., T.C., D.P., G.R.; Supervision: R.C., M.M., D.P. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Communications Medicine thanks Farzana Ali, Gregory Barnes, Leandro Castaneyra-Ruiz, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Agarwal, N., Frigerio, G., Rizzato, G. et al. Parasagittal dural volume correlates with cerebrospinal fluid volume and developmental delay in children with autism spectrum disorder. Commun Med 4, 191 (2024). https://doi.org/10.1038/s43856-024-00622-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s43856-024-00622-8
- Springer Nature Limited